{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T16:43:40Z","timestamp":1780332220702,"version":"3.54.1"},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/100007365","name":"Fondazione IRCCS Policlinico San Matteo","doi-asserted-by":"publisher","award":["Ricerca corrente projects"],"award-info":[{"award-number":["Ricerca corrente projects"]}],"id":[{"id":"10.13039\/100007365","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cardiovasc Diabetol"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s12933-015-0254-8","type":"journal-article","created":{"date-parts":[[2015,7,29]],"date-time":"2015-07-29T10:20:56Z","timestamp":1438165256000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["A study about the relevance of adding acetylsalicylic acid in primary prevention in subjects with type 2 diabetes mellitus: effects on some new emerging biomarkers of cardiovascular risk"],"prefix":"10.1186","volume":"14","author":[{"given":"Giuseppe","family":"Derosa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amedeo","family":"Mugellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa M","family":"Pesce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"D\u2019Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Maffioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,7,30]]},"reference":[{"key":"254_CR1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","volume":"94","author":"DR Whiting","year":"2011","unstructured":"Whiting DR, Guariguata L, Weil C, Shaw J (2011) IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030. Diabetes Res Clin Pract 94:311\u2013321","journal-title":"Diabetes Res Clin Pract"},{"issue":"2","key":"254_CR2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/diacare.16.2.434","volume":"16","author":"J Stamler","year":"1993","unstructured":"Stamler J, Vaccaro O, Neaton JD, Wentworth D (1993) Diabetes, other risk factors, and 12-year cardiovascular mortality for men screened in the Multiple Risk Factor Intervention Trial. Diabetes Care 16(2):434\u2013444","journal-title":"Diabetes Care"},{"issue":"12","key":"254_CR3","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00125-006-0493-z","volume":"49","author":"HE Mulnier","year":"2006","unstructured":"Mulnier HE, Seaman HE, Raleigh VS, Soedamah-Muthu SS, Colhoun HM, Lawrenson RA et al (2006) Risk of stroke in people with type 2 diabetes in the UK: a study using the general practice research database. Diabetologia 49(12):2859\u20132865","journal-title":"Diabetologia"},{"issue":"9","key":"254_CR4","doi-asserted-by":"crossref","first-page":"2566","DOI":"10.2337\/dc12-1781","volume":"36","author":"O Vaccaro","year":"2013","unstructured":"Vaccaro O, Franzini L, Miccoli R, Cavalot F, Ardig\u00f2 D, Boemi M et al (2013) MIND.IT Study Group. Feasibility and effectiveness in clinical practice of a multifactorial intervention for the reduction of cardiovascular risk in patients with type 2 diabetes: the 2-year interim analysis of the MIND.IT study: a cluster randomized trial. Diabetes Care 36(9):2566\u20132572","journal-title":"Diabetes Care"},{"key":"254_CR5","unstructured":"http:\/\/www.aemmedi.it\/news\/single\/1\/standard_italiani_per_la_cura_del_diabete_mellito_2014\/ . Accessed Jan 2015"},{"issue":"Suppl 1","key":"254_CR6","first-page":"S1","volume":"38","author":"American Diabetes Association","year":"2015","unstructured":"American Diabetes Association (2015) Standards of medical care in diabetes-2015. Diabetes Care 38(Suppl 1):S1\u2013S94","journal-title":"Diabetes Care"},{"issue":"5","key":"254_CR7","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1177\/2042098612451267","volume":"3","author":"C Sirois","year":"2012","unstructured":"Sirois C, Couture J, Gr\u00e9goire JP (2012) Acetylsalicylic acid for primary prevention of cardiovascular diseases in older patients with diabetes: do the benefits overcome the risks? Ther Adv Drug Saf 3(5):213\u2013226","journal-title":"Ther Adv Drug Saf"},{"key":"254_CR8","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1001\/jama.2008.623","volume":"300","author":"H Ogawa","year":"2008","unstructured":"Ogawa H, Nakayama M, Morimoto T, Uemura S, Kanauchi M, Doi N et al (2008) Low-dose aspirin for primary prevention of atherosclerotic events in patients with type 2 diabetes: a randomized controlled trial. JAMA 300:2134\u20132141","journal-title":"JAMA"},{"key":"254_CR9","doi-asserted-by":"crossref","first-page":"a1840","DOI":"10.1136\/bmj.a1840","volume":"337","author":"J Belch","year":"2008","unstructured":"Belch J, MacCuish A, Campbell I, Cobbe S, Taylor R, Prescott R et al (2008) The prevention of progression of arterial disease and diabetes (POPADAD) trial: factorial randomised placebo controlled trial of aspirin and antioxidants in patients with diabetes and asymptomatic peripheral arterial disease. BMJ 337:a1840","journal-title":"BMJ"},{"issue":"9","key":"254_CR10","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1185\/03007995.2012.717527","volume":"28","author":"G Derosa","year":"2012","unstructured":"Derosa G, D\u2019Angelo A, Mugellini A, Pesce RM, Fogari E, Maffioli P (2012) Evaluation of emerging biomarkers in cardiovascular risk stratification of hypertensive patients: a 2-year study. Curr Med Res Opin 28(9):1435\u20131445","journal-title":"Curr Med Res Opin"},{"issue":"1","key":"254_CR11","first-page":"88","volume":"28","author":"L Ryd\u00e9n","year":"2007","unstructured":"Ryd\u00e9n L, Standl E, Bartnik M, VandenBerghe G, Betteridge J, deBoer MJ et al (2007) Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The task force on diabetes and cardiovascular diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD). Eur Heart J 28(1):88\u2013136","journal-title":"Eur Heart J"},{"issue":"12","key":"254_CR12","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1093\/clinchem\/45.12.2136","volume":"45","author":"N Rifai","year":"1999","unstructured":"Rifai N, Tracy RP, Ridker PM (1999) Clinical efficacy of an automated high-sensitivity C-reactive protein assay. Clin Chem 45(12):2136\u20132141","journal-title":"Clin Chem"},{"issue":"8","key":"254_CR13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/90984","volume":"7","author":"T Yamauchi","year":"2001","unstructured":"Yamauchi T, Kamon J, Waki H, Terauchi Y, Kubota N, Hara K et al (2001) The fat-derived hormone adiponectin reverses insulin resistance associated with both lipoatrophy and obesity. Nat Med 7(8):941\u2013946","journal-title":"Nat Med"},{"key":"254_CR14","volume-title":"The cytokine handbook","author":"M Zhang","year":"1988","unstructured":"Zhang M, Tracey K (1988) The cytokine handbook, 3rd edn. Academic Press, San Diego","edition":"3"},{"key":"254_CR15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/cyto.b.20021","volume":"61","author":"SS Khan","year":"2004","unstructured":"Khan SS, Smith MS, Reda D, Suffredini AF, McCoy JP Jr (2004) Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B Clin Cytom 61:35\u201339","journal-title":"Cytometry B Clin Cytom"},{"issue":"8","key":"254_CR16","doi-asserted-by":"crossref","first-page":"3844","DOI":"10.1016\/S0021-9258(18)61433-4","volume":"262","author":"K Morishita","year":"1987","unstructured":"Morishita K, Kubota N, Asano S, Kaziro Y, Nagata S (1987) Molecular cloning and characterization of cDNA for human myeloperoxidase. J Biol Chem 262(8):3844\u20133851","journal-title":"J Biol Chem"},{"issue":"12","key":"254_CR17","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1002\/eji.1830221226","volume":"22","author":"D Graf","year":"1992","unstructured":"Graf D, Korth\u00e4uer U, Mages HW, Senger G, Kroczek RA (1992) Cloning of TRAP, a ligand for CD40 on human T cells. Eur J Immunol 22(12):3191\u20133194","journal-title":"Eur J Immunol"},{"key":"254_CR18","volume-title":"Statistical principles in experimental design","author":"BJ Winer","year":"1971","unstructured":"Winer BJ (1971) Statistical principles in experimental design, 2nd edn. McGraw-Hill, New York","edition":"2"},{"issue":"2","key":"254_CR19","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cyto.2014.01.003","volume":"66","author":"J Vaucher","year":"2014","unstructured":"Vaucher J, Marques-Vidal P, Waeber G, Vollenweider P (2014) Cytokines and hs-CRP levels in individuals treated with low-dose aspirin for cardiovascular prevention: a population-based study (CoLaus study). Cytokine 66(2):95\u2013100","journal-title":"Cytokine"},{"issue":"5","key":"254_CR20","doi-asserted-by":"crossref","first-page":"545","DOI":"10.5603\/CJ.2013.0045","volume":"20","author":"M Rosiak","year":"2013","unstructured":"Rosiak M, Postula M, Kaplon-Cieslicka A, Kondracka A, Trzepla E, Czlonkowski A et al (2013) Effect of ASA dose doubling versus switching to clopidogrel on plasma inflammatory markers concentration in patients with type 2 diabetes and high platelet reactivity: the AVOCADO study. Cardiol J. 20(5):545\u2013551","journal-title":"Cardiol J."},{"key":"254_CR21","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1186\/1475-2840-12-87","volume":"12","author":"Y Takahashi","year":"2013","unstructured":"Takahashi Y, Nishida Y, Nakayama T, Asai S (2013) Comparative effect of clopidogrel and aspirin versus aspirin alone on laboratory parameters: a retrospective, observational, cohort study. Cardiovasc Diabetol 12:87","journal-title":"Cardiovasc Diabetol"},{"key":"254_CR22","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1186\/s12933-014-0112-0","volume":"13","author":"A Kaplon-Cieslicka","year":"2014","unstructured":"Kaplon-Cieslicka A, Postula M, Rosiak M, Peller M, Kondracka A, Serafin A et al (2014) Younger age, higher body mass index and lower adiponectin concentration predict higher serum thromboxane B2 level in aspirin-treated patients with type 2 diabetes: an observational study. Cardiovasc Diabetol 13:112","journal-title":"Cardiovasc Diabetol"},{"issue":"5","key":"254_CR23","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1177\/1074248413489772","volume":"18","author":"BK Irons","year":"2013","unstructured":"Irons BK, Trujillo A, Seifert CF, Simoni JS, Doctolero S, Abo-Salem E et al (2013) Effects of direct renin inhibition on atherosclerotic biomarkers in patients with stable coronary artery disease and type 2 diabetes mellitus. J Cardiovasc Pharmacol Ther 18(5):427\u2013432","journal-title":"J Cardiovasc Pharmacol Ther"},{"key":"254_CR24","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1758-5996-6-56","volume":"6","author":"M Tanaka","year":"2014","unstructured":"Tanaka M, Nishimura R, Nishimura T, Kawai T, Meguro S, Irie J et al (2014) Effect of single tablet of fixed-dose amlodipine and atorvastatin on blood pressure\/lipid control, oxidative stress, and medication adherence in type 2 diabetic patients. Diabetol Metab Syndr 6:56","journal-title":"Diabetol Metab Syndr"},{"key":"254_CR25","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000355136","volume":"3","author":"BV Khan","year":"2013","unstructured":"Khan BV, Merchant N, Rahman ST, Ahmad M, Parrott JM, Umar K et al (2013) Changes in central aortic pressure, endothelial function and biomarkers in hypertensive african-americans with the cardiometabolic syndrome: comparison of amlodipine\/olmesartan versus hydrochlorothiazide\/losartan. Cardiorenal Med 3:221\u2013231","journal-title":"Cardiorenal Med"},{"issue":"25","key":"254_CR26","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1038\/newbio231232a0","volume":"231","author":"JR Vane","year":"1971","unstructured":"Vane JR (1971) Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs. Nat New Biol 231(25):232\u2013235","journal-title":"Nat New Biol"},{"issue":"1","key":"254_CR27","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0031-6997(25)06634-7","volume":"26","author":"RJ Flower","year":"1974","unstructured":"Flower RJ (1974) Drugs which inhibit prostaglandin biosynthesis. Pharmacol Rev 26(1):33\u201367","journal-title":"Pharmacol Rev"},{"issue":"1","key":"254_CR28","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1182\/blood.V69.1.180.180","volume":"69","author":"IA Reilly","year":"1987","unstructured":"Reilly IA, FitzGerald GA (1987) Inhibition of thromboxane formation in vivo and ex vivo: implications for therapy with platelet inhibitory drugs. Blood 69(1):180\u2013186","journal-title":"Blood"},{"issue":"3","key":"254_CR29","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1177\/1074248406292263","volume":"11","author":"CH Hennekens","year":"2006","unstructured":"Hennekens CH, Sechenova O, Hollar D, Serebruany VL (2006) Dose of aspirin in the treatment and prevention of cardiovascular disease: current and future directions. J Cardiovasc Pharmacol Ther 11(3):170\u2013176","journal-title":"J Cardiovasc Pharmacol Ther"},{"issue":"3\u20134","key":"254_CR30","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/0049-3848(80)90066-3","volume":"17","author":"C Patrono","year":"1980","unstructured":"Patrono C, Ciabattoni G, Pinca E, Pugliese F, Castrucci G, De Salvo A et al (1980) Low dose aspirin and inhibition of thromboxane B2 production in healthy subjects. Thromb Res 17(3\u20134):317\u2013327","journal-title":"Thromb Res"},{"issue":"11","key":"254_CR31","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1172\/JCI35874","volume":"118","author":"T Weissm\u00fcller","year":"2008","unstructured":"Weissm\u00fcller T, Campbell EL, Rosenberger P, Scully M, Beck PL, Furuta GT et al (2008) PMNs facilitate translocation of platelets across human and mouse epithelium and together alter fluid homeostasis via epithelial cell-expressed ecto-NTPDases. J Clin Invest 118(11):3682\u20133692","journal-title":"J Clin Invest"},{"issue":"21","key":"254_CR32","doi-asserted-by":"crossref","first-page":"9475","DOI":"10.1073\/pnas.92.21.9475","volume":"92","author":"J Cl\u00e0ria","year":"1995","unstructured":"Cl\u00e0ria J, Serhan CN (1995) Aspirin triggers previously undescribed bioactive eicosanoids by human endothelial cell-leukocyte interactions. Proc Natl Acad Sci USA 92(21):9475\u20139479","journal-title":"Proc Natl Acad Sci USA"},{"issue":"5291","key":"254_CR33","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1126\/science.274.5291.1383","volume":"274","author":"M Grilli","year":"1996","unstructured":"Grilli M, Pizzi M, Memo M, Spano P (1996) Neuroprotection by aspirin and sodium salicylate through blockade of NF-kappaB activation. Science 274(5291):1383\u20131385","journal-title":"Science"},{"issue":"3","key":"254_CR34","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","volume":"183","author":"T Morris","year":"2009","unstructured":"Morris T, Stables M, Hobbs A, de Souza P, Colville-Nash P, Warner T et al (2009) Effects of low-dose aspirin on acute inflammatory responses in humans. J Immunol 183(3):2089\u20132096","journal-title":"J Immunol"}],"container-title":["Cardiovascular Diabetology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12933-015-0254-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T20:01:10Z","timestamp":1748548870000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.cardiab.com\/content\/14\/1\/95"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,7,30]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["254"],"URL":"https:\/\/doi.org\/10.1186\/s12933-015-0254-8","relation":{},"ISSN":["1475-2840"],"issn-type":[{"value":"1475-2840","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,7,30]]},"article-number":"95"}}